Inbio to Buy Back Up to 10% of Issued Shares
Inbio will begin a full-scale buyback of its own shares starting next year.
Inbio announced on the 25th that it is considering the purchase of treasury shares equivalent to 5% to 10% of its total issued shares next year. A treasury stock buyback is a representative shareholder return policy that can reduce the number of shares in circulation and is expected to have the effect of increasing earnings per share (EPS) and per-share value.
Inbio recently secured funds worth 20 billion won, thereby establishing a financial foundation to pursue policies aimed at enhancing shareholder value.
Management accountability efforts are also continuing. CEO Lee Myoungjae purchased 108,383 treasury shares on the open market over a five-month period starting in October last year.
Hot Picks Today
"Two Spend 500,000 Won in a Flash, Yet Wait Two Hours?" ... 'Dreamland' Shunned by Kids and Foreign Tourists
- The Era of Getting 200 Million Won After 30 Years Is Over... A Japanese Bank's "Perpetual Department Head" Who Just Clocked In Cries Out
- Spain Hit by Its Worst Tragedy... Lee Kangin, Moreno and Real Madrid Join Soccer World in Mourning
- They Said, “Make It Your Home for Life” - Then Suddenly Kicked 200 Passengers Off... What Happened to the Around-the-World Cruise?
- "130 Rice Bowls Sold Out in a Day"... 'Unfiltered Face' Adds 8 Million Won to Night Market Sales: China's Bungeunwoo
Meanwhile, at an extraordinary general meeting of shareholders held on the 17th, Inbio approved as originally proposed the agenda item to transfer capital reserves to retained earnings in order to offset accumulated deficits.
© The Asia Business Daily. All rights reserved. Unauthorized AI training and use prohibited.